Introduction
The transcription factor p53 has been referred to as 'the guardian of the genome' and functions as a critical regulator in cell fate determination under genotoxic stresses. p53 is normally present in a latent state and is maintained at low levels by constitutive degradation via the binding of E3 ubiquitin ligases, such as MDM2/HDM2, Pirh2, COP1 or ARF-BP1. Various stress stimuli initiate signaling pathways to increase the protein stability and the transcriptional activity of p53, which subsequently induces the expression of a large number of p53 downstream target genes. Induced activation of p53-dependent signaling events exerts multiple effects including growth arrest and apoptosis, depending on the cell types and the nature of the stimuli (Levine et al., 2006; Liu and Chen, 2006; Olsson et al., 2007; Brooks and Gu, 2008; Kruse and Gu, 2009) .
Posttranslational modifications, including ubiquitination, phosphorylation and acetylation, have critical roles in regulating p53 protein stability and transcriptional activity under various stress conditions (Haupt et al., 1997; Sakaguchi et al., 1998; Li et al., 2002; Feng et al., 2005; Brooks and Gu, 2008; Tang et al., 2008; Eischen and Lozano, 2009 ). The inducible phosphorylation of p53, especially at the N-terminal serine and threonine residues, is assumed to change the conformation of this protein, thereby prevents the p53-MDM2 interaction and consequently disrupts MDM2-dependent degradation and promotes the accumulation of p53 (Haupt et al., 1997; Kubbutat et al., 1997; Brooks and Gu, 2003; Eischen and Lozano, 2009; Kruse and Gu, 2009 ). Acetylation of p53 has been identified to occur at several lysine residues within the C-terminal regulatory domain and/or the DNA-binding domain under various stress stimuli, which is carried out by histone acetyltransferases (HATs), such as p300/CREB-binding protein (CBP), p300/CBP-associated factor and Tip60 (Gu and Roeder, 1997; Liu et al., 1999; Sykes et al., 2006; Tang et al., 2006 Tang et al., , 2008 . Under most cases, p300/ CBP-mediated p53 acetylation at the lysine residues in the C-terminal domain of p53 has been well studied and is thought to divert this protein from ubiquitination and degradation, and therefore stabilizes p53 (Li et al., 2002) . In addition, acetylation of p53 at these sites also promotes its transcriptional activity by increasing the DNA-binding ability of p53 or facilitates the recruitment of its co-activators (that is, p300) to the promoter regions of p53-responsive genes (Gu and Roeder, 1997; Sakaguchi et al., 1998; Luo et al., 2004) . Therefore, C-terminal acetylation of p53 is essential for both the accumulation and the transactivation of p53; although the controversy regarding these outcome of p53 acetylation exists (Li et al., 2002; Feng et al., 2005; Brooks and Gu, 2008 ; Kruse and Gu, 2009 ). Recent reports by Gu and colleagues have further disclosed that modifications at two additional lysine residues within the DNA-binding domain of p53 can compensate for the acetylation defects in its C-terminus, and thereby, mediate the transactivation of p53 in response to certain stress signals (Tang et al., 2006 . These novel discoveries further confirm that p53 acetylation is an indispensable event for mediating the p53 response. However, the regulatory mechanisms involving in this posttranslational modification are still largely unknown (Kruse and Gu, 2009 ).
p85a is the major regulatory subunit of phosphatidylinositol-3-kinase (PI-3K; Geering et al., 2007) . In addition to forming a complex with the p110 catalytic subunit and subsequently regulating PI-3K activity, p85a also exists in a monomeric form because of the greater abundance of p85a than p110 in many cell types (Ueki et al., 2002a; Geering et al., 2007) . Therefore, it is reasonable to assume that p85a may also function independently of PI-3K. In one of our recent studies, we have reported that genetic ablation of the p85a gene in mouse embryonic fibroblasts (MEFs) endows these cells with resistance to ultraviolet B (UVB)-induced apoptosis, indicating the specific role of p85a in mediating the UVB-induced cell apoptotic response. Further investigations have also shown that this proapoptotic effect of p85a is unrelated to PI-3K activity and is elicited by the induction of tumor necrosis factor (TNF)a expression (Song et al., 2007) . However, as suppression of TNFa induction by its specific small interfering RNA only modestly attenuates UVB-induced apoptosis in MEFs; therefore, we propose that p85a may exert its proapoptotic effect through other pathways in addition to TNFa induction. In this study, we further reveal a novel function of p85a as an upstream mediator for p300-mediated p53 acetylation at Lys370, which consequently enhances promoter-specific p53 transcriptional activity to mediate the cell apoptotic effect in response to UVB.
Results

p85a is involved in p53 transactivation under UVB exposure
Our previous study has demonstrated the PI-3K-independent role of p85a in mediating UVB-induced cell apoptosis in MEFs partially by inducing TNFa expression (Song et al., 2007) . Here, we also found that p85a deficiency renders MEFs more resistant to UVBinduced apoptosis, which effect can be effectively restored by ectopic expression of p85a in the null cells ( Figure 1a) . We next reasoned whether p85a had any effect on modulating p53 activity because of its key role in the mediation of cellular apoptosis under various stresses including UVB irradiation (Latonen and Laiho, 2005; Kruse and Gu, 2009) . To this end, we first stably transfected a p53-luciferase reporter construct (Wang et al., 2005) into wild-type (p85a þ / þ ) and p85a-null MEFs. As indicated in Figure 1b , after UVB exposure, a significant induction of p53-dependent luciferase activity was readily detected in the p85a þ / þ MEFs within 24 h. However, this induction was dramatically suppressed in p85a À/À MEFs under the same experimental conditions. This result suggests that p85a has a role in the regulation of p53 transactivation in the UVB response. We next tested the induction of the well-characterized p53 transcriptional targets in both p85a
þ / þ and p85a
À/À MEFs exposed to UVB irradiation. As shown in Figure 1c , among the genes examined, induced transcription of PERP and DR5 was obviously observed in p85a þ / þ MEFs, whereas such induction was markedly impaired in p85a À/À MEFs under the same UVB exposure conditions. Induction of PERP and DR5 was strictly p53-dependent because no transcription of these two genes was observed in UVB-treated p53 À/À MEFs (see below in Figure 6d ). By contrast, protein levels of BAX and PUMA were comparable in p85a þ / þ and p85a À/À MEFs and did not change before and after UVB exposure ( Figure 1d ). These data thus have excluded the involvement of BAX and PUMA in the p53-dependent UVB response in MEFs. Interestingly, in the UVBtreated wild-type (WT) MEFs, we also found an upregulation of GADD45a and p21 levels, which are common indicators of p53 function (Latonen and Laiho, 2005) . However, these reactions have not been obviously altered by p85a deficiency (Figure 1d ), indicating the involvement of p85a-independent pathway(s) in GADD45a and p21 induction in response to UVB irradiation. These data together indicate that p85a regulates p53 transcriptional activity and the induction of specific p53-responsive genes in the UVB response.
To further confirm that the impairment of p53 transactivation in UVB-treated p85a À/À MEFs was indeed due to the specific deficiency of p85a expression other than non-specific gene changes during the establishment of the p85a À/À MEFs, we next detected whether p53 transactivation could be restored in p85a-reconstituted p85a-null cells (Song et al., 2007) . As shown in Figures 1e and f, reintroduction of the p85a gene into p85a À/À MEFs effectively rescued the induction of p53-dependent luciferase activity as well as the upregulation of PERP and DR5 expression during the UVB response, although the dynamic changes of DR5 induction showed a slight difference between the WT and the reconstituted null cells under the same conditions ( Figure 1f) .
We next further substantiated the above findings obtained in p85a À/À MEFs by utilizing p85a þ / þ MEFs stably transfected with specific p85a small hairpin RNA (shRNA; Song et al., 2007) . We also observed a decreased apoptotic response in p85a shRNA-transfected cells compared with the control cells under UVB exposure, evidenced by the suppression of UVB-induced caspase-3 cleavage by specific knockdown of p85a levels ( Figure 1g ). And as expected, the phenotype of UVB-induced p53 transactivation, as well as PERP/DR5 transcription, is significantly inhibited in the shRNAtransfected cells (Figures 1h and i) . Taken together, these data suggest that p85a is required for promoter-specific p53 transactivation during the UVB response.
Inducible accumulation, phosphorylation and nuclear translocation of p53 under UVB are not affected by p85a depletion The cellular level of p53 is continuously maintained at a low level via targeting to the ubiquitination-mediated degradation pathway in resting cells (Haupt et al., 1997; Kubbutat et al., 1997) . In response to stress signals, p53 becomes stabilized through posttranslational modifications and then translocates into the nucleus to induce the expression of p53 responsive genes (Kruse and Gu, To address the potential mechanism by which p85a regulates p53 transactivation, we next detected whether p85a exerts any effects on modulating UVBinduced p53 accumulation, phosphorylation, acetylation and nuclear translocation in MEFs. As indicated in Figures 2a and b , UVB irradiation induced both dose-and time-dependent accumulation of p53 at the comparable levels in WT and p85a À/À MEFs. Moreover, accumulated p53 proteins were also induced to translocate into the nucleus at almost the same efficacy in both cell types (Figure 2c ). These results indicate that the mechanism activated by UVB for mediating p53 stabilization and nuclear accumulation is not affected by genetic ablation of p85a.
Next, we determined the phosphorylation status of p53 in UVB-treated p85a þ / þ and p85a À/À MEFs. Because of the limitation of the commercially available phosphorylation-specific antibodies against mouse p53, we only examined the phosphorylation of mouse p53 at Ser18, 23, 389 and Thr 21 (Ser15, 20, 392 and Thr18 of human p53) during the UVB response, respectively. In dose-and time-dependent experiments analyzing the potential phosphorylation sites, we observed strong and comparable induction of p53 phosphorylation at Ser18 and Ser389 in both UVB-treated p85a þ / þ and p85a
cells (Figures 2a and b)
. The modification of other residues was faint (Ser23) or moderate (Thr21), and did not show any obvious differences in the presence or absence of p85a expression (data not shown). These data strongly suggest that p85a is not involved in p53 phosphorylation during the UVB response.
In the following study, we further confirm the above findings using p85a shRNA-transfected WT MEFs. As indicated in Figure 2d , UVB-induced p53 accumulation and phosphorylation at both Ser18 and Ser389 were not altered by knockdown of p85a expression in MEFs. These data are consistent with the observations obtained in the p85a-null cells.
p85a is required for p53 acetylation at Lys370 in response to UVB Numerous studies have validated that acetylation of human p53 at the lysine residues located at the C-terminus (Lys320, 370, 372, 373, 381, 382) has a critical role in regulating its transcriptional activity (Gu and Roeder, 1997; Chao et al., 2006; Sykes et al., 2006; Tang et al., 2006 Tang et al., , 2008 Kruse and Gu, 2009 ). Moreover, p300/CBP-mediated p53 acetylation at Lys373/382 is highly conserved and preferentially induced in response to the various stress signals to mediate p53-dependent growth arrest and apoptotic effects (Gu and Roeder, 1997; Goodman and Smolik, 2000; Grossman, 2001) . Therefore, in the following study, we examined whether p85a achieves its regulatory effect on p53 transactivation in the UVB response by modulating p53 acetylation. As shown in Figure 3a , by performing immunoprecipitation with an anti-p53 antibody and then probing with acetylation-specific antibodies that recognize AC-Lys370 and AC-Lys379 of mouse p53 (AC-Lys373 and AC-Lys382 of human p53), acetylation of mouse p53-Lys370 was readily observed 8 h after UVB exposure in the presence of p85a and gradually decreased to the basal level within 24 h. However, this modification was greatly impaired by p85a depletion under the same conditions, although p53 accumulated at comparable levels in the p85a þ / þ and p85a À/À cells. By contrast, the kinetics of the inducible acetylation of p53 at Lys379 in response to UVB irradiation did not show obvious difference in the presence or absence of p85a expression ( Figure 3a ). When UVB-accumulated p53 was immuno precipitated in both WT and p85a-null cells and then subjected to the detection of acetylation at Lys317 (Lys320 of human p53), modification at which site has been demonstrated to suppress the transcriptional activity and proapoptotic effect of p53 after DNA damage (Chao et al., 2006) , we failed to observe the signal that indicates the acetylation of p53 at Lys317 under UVB exposure, either in the presence or absence of p85a expression (data not shown). These data imply a critical role of p85a in regulating p53 acetylation specifically at Lys370 in the UVB response.
To avoid off-target effects in p85a À/À MEFs, we next analyzed the UVB-induced modification of p53 at Lys370 occurring in the reconstituted p85a-null cells and p85a shRNA-transfected WT cells. As shown in Figures 3b and c, introduction of p85a into the p85-null cells partially restored the phenotype of UVB-induced Lys370 acetylation of p53, and knockdown of p85a levels in WT MEFs by shRNA transfection, also þ / þ , p85a À/À and reconstituted p85a À/À (p85a) MEFs were exposed to UVB (1 kJ/m 2 ), and then cell apoptosis was determined by flow cytometric assay at the indicated time points after UVB exposure. (b) p85a þ / þ and p85a À/À MEFs with the stable transfection of the p53-luciferase reporter construct were exposed to UVB (1 kJ/m 2 ) for the indicated time periods, and then the p53 luciferase activities were measured. The results were expressed as the relative p53 luciferase activities, which were normalized to the luciferase activity of the cells without any treatment. (c, d) p85a
þ / þ and p85a À/À MEFs were exposed to the UVB (1 kJ/m 2 ) for the indicated time periods, and then the expression of p53-target genes including DR5, PERP, PUMA, BAX, GADD45a and p21 were detected by semi-quantitative reverse transcription-PCR (RT-PCR) (c) and western blot assays (d) . (e) p85a þ / þ , p85a À/À and p85a À/À (p85a) MEFs with the stable transfection of the p53-luciferase reporter construct were exposed to UVB (1 kJ/m 2 ) for the indicated time periods, and then the p53 luciferase activities were measured.
À/À and p85a À/À (p85a) MEFs were exposed to UVB (1 kJ/m 2 ) for the indicated time periods and then the transcriptional induction of PERP and DR5 were detected by semi-quantitative RT-PCR assay. (g) p85a þ / þ (control shRNA) and p85a þ / þ (p85a shRNA) MEFs were exposed to UVB (1 kJ/m 2 ), and then cell apoptosis was determined by detecting caspase-3 cleavage at the indicated time points after UVB exposure. (h) p85a þ / þ (control shRNA) and p85a þ / þ (p85a shRNA) MEFs with the stable transfection of the p53-luciferase reporter construct were exposed to UVB (1 kJ/m 2 ) for the indicated time periods, and then the p53 luciferase activities were measured. (i) p85a
þ / þ (control shRNA) and p85a þ / þ (p85a shRNA) MEFs were exposed to UVB (1 kJ/m 2 ) for the indicated time periods, and then the transcriptional induction of PERP and DR5 were detected by semi-quantitative RT-PCR assay.
p85a-dependent p53 acetylation in UVB response L Song et al significantly suppressed the modification of p53 at this lysine residue, which response can be recovered by reconstitution of p85a expression. These data clearly indicated that p85a is required for the induction of p53 acetylation at Lys370 in the cellular response to UVB irradiation.
p85a interacts with p300 and enhances the p300-p53 interaction, as well as the autoacetylation of p300 in response to UVB irradiation A variety of studies have demonstrated that the signaling event of human p53 acetylation at Lys373 involves the recruitment and function of p300/CBP, the HAT activity-containing co-activators that can acetylate p53 and the histones located in the vicinity of the Figure 3 p85a is required for p53 acetylation at Lys370 in the UVB response. (a) p85a þ / þ and p85a À/À MEFs were exposed to UVB (1 kJ/m 2 ) for the indicated time periods, and then whole cell extracts were immunoprecipitated with the anti-p53 antibody. The immunoprecipitated samples were probed with anti-p53-AC-K370 and anti-p53-AC-K379 antibodies to detect the acetylation of p53 at Lys370 and Lys379 in the UVB response. Total p53 levels were detected in the whole cell extract.
(p85a) MEFs were exposed to UVB (1 kJ/m 2 ) for 8 h, and then the accumulation and acetylation of p53 at Lys370 and Lys379 were detected as described above. (c) p85a
þ / þ (p85a shRNA) MEFs were left untreated or transiently transfected with p85a expression plasmid. After 36 h, the transfected cells and the p85a þ / þ (control shRNA) MEFs were exposed to UVB (1 kJ/m 2 ) for 8 h, and then the accumulation and acetylation of p53 at Lys370 and Lys379 were detected. IP, immunoprecipitation. À/À MEFs were exposed to UVB (1 kJ/m 2 ) for 12 h, and then the cytoplasmic and nuclear proteins were extracted and subjected to the western blot assay to determine the nuclear translocation of p53.
þ / þ (control shRNA) and p85a þ / þ (p85a shRNA) MEFs were exposed to UVB (1 kJ/m 2 ) for the indicated time periods, and then the accumulation and phosphorylation of p53 (Ser18, Ser389) were detected as described above.
promoter region of the p53-responsive genes. Moreover, p300/CBP functions as the bridge molecule to increase the binding of p53 to the DNA-responsive elements, which subsequently enhances the transcriptional activity of p53 (Gu and Roeder, 1997; Grossman, 2001; Iyer et al., 2004) . Therefore in the following study, we wished to determine whehter the role of p85a in p53 acetylation involves any regulatory effect of p300. We first detected whether p85a interacts with p300 in the UVB response by performing immunoprecipitation experiments in 293T cells co-transfected with GFP-p85a and HA-p300. When ectopically overexpressed p85a in the cell lysate was immunoprecipitated with an anti-GFP antibody, p300 coimmunoprecipitated with p85a 4-12 h after UVB exposure; however, no binding of these two molecules was detected in the untreated cells (Figure 4a ). To further confirm these findings, we next detected whether the binding of endogenous p85a with p300 occurs under UVB. As shown in Figure 4b , immunoprecipitation of NIH3T3 cell lysates with anti-p300 antibody and subsequent immunoblot analysis with the anti-p85a antibody clearly indicated an interaction between endogenous p85a with p300 in response to UVB exposure. We then detected whether p85a exerted a positive effect on the p300-p53 interaction under UVB irradiation. To this end, we immunoprecipitated comparably accumulated p53 in UVB-treated p85a þ / þ and p85a
À/À
MEFs and then examined the amount of endogenous p300 binding with p53 by immunoblotting with the antip300 antibody. Data shown in Figure 4c clearly indicated that the recruitment of p300 to p53 significantly increased 4-12 h after UVB exposure in the presence of p85a; however, this response was Figure 4 p85a interacts with p300, enhances p300-p53 interaction and the autoacetylation of p300 in the cellular response to UVB irradiation. (a) 293T cells were co-transfected with the expression plasmids containing HA-p300 and GFP-p85a or the control vector. After 36 h of transfection, the cells were exposed to UVB as the indicated time periods, and then whole cell lysates were immunoprecipitated with the anti-GFP antibody. The immunoprecipitated samples were then probed with anti-p300 antibody to determine the interaction between p85a and p300 under UVB irradiation. (b) NIH3T3 cell lysates were immunoprecipitated with antip300 antibody or control immunoglobulin G (IgG), and then the immunoprecipitated samples were probed with the anti-p85a antibody to detect the binding of endogenous p85a to p300. (c-e) The samples described in Figures 3a-c were probed with anti-p300 and anti-p300-AC-Lys1499 antibodies to detect the binding of p300 to p53 and the autoacetylation of p300 under UVB irradiation, respectively. IP, immunoprecipitation.
p85a-dependent p53 acetylation in UVB response L Song et al dramatically inhibited in p85a À/À MEFs under the same conditions. Moreover, UVB-induced p300-p53 interaction was rescued in the null cells by p85a reconstitution (Figure 4d) , and was dramatically reduced in p85a shRNA-transfected WT MEFs (Figure 4e ). These data together indicate that p85a is involved in regulating p300-p53 complex formation and the subsequent p53 acetylation in the cellular UVB response.
Autoacetylation of p300 at lysine residues within the HAT domain has been demonstrated to stimulate its acetyltransferase activity and enhance p300-p53 complex formation in response to stress signals (Goodman and Smolik, 2000) . Therefore in the following study, coupled immunoprecipitation and immunoblot assays were performed to detect the acetylation status of p53-associated p300 in the UVB response. As shown in Figures 4c-e , autoacetylation of p53-associated p300 was strongly induced in the presence of p85a 4-12 h after UVB exposure. Furthermore, this response was dramatically suppressed by genetic ablation of p85a and restored by p85a reconstitution and, as expected, was downregulated by p85a shRNA transfection. Because both p85a-regulated autoacetylation of p300 and p300-p53 interaction occurred 4 h earlier than p53 Lys370 acetylation under UVB exposure (Figures 3a and 4c) , we conclude that p85a is necessary for UVB-induced p300-p53 interaction and p300 autoacetylation, which events may subsequently contribute to an increase in p53 acetylation.
p85a-dependent p53 acetylation is essential for the promoter-specific binding ability of p53
To further confirm the contribution of the p85a-dependent p53-p300 interaction and p53 acetylation (Lys370) to UVB-induced p53 transactivation, we next analyzed the recruitment of p300 and p53 to the p53-responsive element (p53-RE) within the promoter region of p53 target genes in response to UVB irradiation in the presence or absence of p85a expression. To this end, a chromatin immunoprecipitation (ChIP) assay was performed using specific antibodies against p53 or p300. As shown in Figure 5a , p53 and p300 were recruited to the p53-RE within the PERP promoter in response to UVB irradiation in p85a
MEFs. However, these events were dramatically impaired by p85a deficiency and effectively restored in the p85a-reconstituted p85a À/À MEFs. When the binding ability of p53 to the endogenous p21 promoter was detected, we have observed the same recruitment efficiency of p53 to the p21 promoter in the presence or absence of p85a expression (Figure 5b ). These data strongly indicate that p85a-dependent acetylation affects the DNA-binding ability of p53 in a promoterspecific manner in the UVB response.
p85a-dependent p53 acetylation at Lys370 is critical for promoter-specific p53 transactivation in the UVB-induced apoptotic response To further determine whether UVB-induced promoterspecific p53 transactivation depends on p85a-mediated p53 acetylation at Lys370, expression plasmids containing wild-type p53 (wt p53) or p53 with a Lys370Arg mutation (K370R) generated by mutagenic PCR were transfected into p53 À/À MEFs. As shown in Figure 6a , compared with the response in wt p53-transfected p53 À/À cells, a point mutation changing lysine 370 to arginine abolished p53 acetylation at this residue, but did not interfere with UVB-induced stabilization of p53 proteins. The following dose-dependent experiment further confirmed that wt p53 and p53K370R accumulated at the comparable levels under individual doses of UVB exposure (Figure 6b ). These results are consistent with the data shown in Figures 2a and 3a and suggest that p53 protein stability is not affected by the disruption of acetylation at Lys370.
Next, we compared the promoter-binding abilities of wt p53 and p53K370R in response to UVB. Chromatin from p53
MEFs transfected with wt p53 or p53K370R was immunoprecipitated with anti-p53 antibody and then analyzed by PCR with the primers specific for the p53-binding regions within endogenous PERP or p21 promoters. As shown in Figure 6c , strong binding of wt p53 to the endogenous PERP promoter was observed under UVB exposure; however, the mutation at Lys370 disrupts the PERP promoter binding ability of p53 significantly. By contrast, the recruitment of wt p53 and p53K370R to the p21 promoter exhibited almost the same efficiency in UVB exposure. These data together further confirm the requirement of Lys370 acetylation for the promoterspecific binding ability of p53. þ / þ , p85a À/À and p85a À/À (p85a) MEFs was subjected to a ChIP assay using the normal immunoglobulin G, anti-p53 or anti-p300 antibodies, respectively. Immunoprecipitated chromatin DNA was PCRamplified with the primers that specifically annealed to the region flanking p53-responsive elements within the promoter region of PERP (a) or p21 (b).
p85a-dependent p53 acetylation in UVB response L Song et al
In the following study, we compared the transactivation of wt p53 and p53K370R in the UVB response. We found that disruption of UVB-induced PERP and DR5 transcription in p53 À/À MEFs was effectively restored by reconstitution of the wt p53 but not of p53K370R (Figure 6d ). But both wt p53 and p53K370R can rescue p21 induction at almost the comparable levels under the same UVB exposure conditions (Figure 6e ). Taken together, these data indicate that p53 acetylation at Lys370 is required for promoter-specific transactivation of p53 in the UVB response.
Finally, we determined the role of p53 acetylation at Lys370 in the UVB-induced apoptotic response. As shown in Figure 6f , impaired apoptosis of p53 À/À MEFs under exposure to UVB can be efficiently restored by ectopic expression of wt p53; however, p53K370R introduction only modestly restored the apoptotic phenotype in p53-null cells under the same UVB treatment. These data indicate that p85a-dependent p53 acetylation is important to deliver the proapoptotic role of p85a in the UVB response. MEFs were transfected with the expression plasmids containing wt p53 or p53K370R. After 36 h of transfection, the cells were exposed to UVB (1 kJ/m 2 ) for 8 h, and the whole cell lysates were immunoprecipitated with the anti-p53 antibody. The immunoprecipitated samples were then probed with anti-p53 or anti-p53-AC-K370 antibodies to detect the accumulation and acetylation (K370) of p53. (b) p53 À/À MEFs were transfected with the expression plasmids containing wt p53, the p53K370R or the control vector (vc). After 36 h of transfection, the cells were exposed to different doses of UVB, and then the accumulation of p53 was detected by a western blot assay. (c) p53
À/À MEFs were transfected with the wt p53 or p53K370R and then exposed to UVB (1 kJ/m 2 ) for 8 h. The ChIP assay was performed using normal serum or the anti-p53 antibody. Immunoprecipitated chromatin DNA was PCRamplified with the primers that specifically annealed to the region flanking p53-responsive elements within the PERP or p21 genes.
À/À MEFs were transfected with the expression plasmids containing wt p53, p53K370R or the control vector. After 36 h of transfection, the cells were exposed to UVB (1 kJ/m 2 ), and the transcription of PERP and DR5 were detected by a reverse transcription PCR assay 12 h after UVB exposure. The same assay performed using WT MEFs was also shown here as a positive control. (e) p53 À/À MEFs were transfected and treated as described in (d), and then the induction of p21 expression was determined by western blot assay 12 h after UVB exposure. (f) p53 À/À MEFs were transfected and treated as described in (d), and then the apoptosis of the transfected cells was determined by a flow cytometric assay 24 h after UVB exposure. IP, immunoprecipitation.
p85a-dependent p53 acetylation in UVB response L Song et al Discussion p85a is a multi-functional protein that serves as the critical mediator in the various physiological processes via PI-3K activity-dependent or -independent mechanisms (Yin et al., 1998; Ueki et al., 2002a, b; Luo et al., 2005; Geering et al., 2007; Manning and Cantley, 2007) . In our recent report, we have disclosed the novel role of p85a in mediating the apoptotic response under UVB exposure partially through the activation of NFAT3/ TNFa pathway in mouse fibroblasts, which events do not involve PI-3K activity (Song et al., 2007) . In the current study, we additionally validated the mechanism of p85a in transmitting the UVB-induced apoptotic response by positively regulating p53 acetylation and transactivation. These data together indicate that coordination of multiple signaling pathways is required for executing the proapoptotic and PI-3K-independent function of p85a under UVB.
Owing to the central role of p53 played in genotoxic and oncogenic stresses, great attention has been focused to elucidate the mechanisms by which p53 protein stability, subcellular localization, posttranslational modification, cofactor binding and transcriptional activity are regulated (Levine et al., 2006; Liu and Chen, 2006; Olsson et al., 2007; Brooks and Gu, 2008; Kruse and Gu, 2009 ). Therefore, numerous protein factors have been found to modulate p53 activity, and then the activation of p53 has been demonstrated to link to the regulation of a variety of downstream signaling molecules (Luo et al., 2001; An et al., 2004; Pedeux et al., 2005; Kim et al., 2007; Sasaki et al., 2007; Cao et al., 2008; Kitagawa et al., 2008; Kurash et al., 2008; Zhao et al., 2008; Pan et al., 2009; Zhu et al., 2009) . Data in the current study have shown that p85a has a critical role in mediating p300-dependent p53 acetylation without regulation of p53 stabilization, nuclear translocation and phosphorylation under UVB exposure. Therefore, as the novel and essential upstream regulator of p53, p85a functions to specifically link to the modulation of p53 acetylation, one of the most important posttranslational modifications responsible for p53 activation in the UVB response. In fact, the previous report from Dr Barrett and colleagues has revealed that p85a also participates in the downstream signaling of the p53 pathway to mediate the apoptotic response to hydrogen peroxide, whose effect is also unrelated to the activation status of the PI-3K signal transduction pathway (Yin et al., 1998) . Therefore, these results have extended our understanding of the proapoptotic role of p85a through a PI-3K-independent mechanism under different stress conditions, either by taking part in the regulatory events upstream of the p53 pathway or functioning as the downstream mediator of p53.
p53 represents the first no-histone substrate functionally regulated by acetylation and deacetylation (Gu and Roeder, 1997; Sakaguchi et al., 1998; Luo et al., 2000 Luo et al., , 2001 Vaziri et al., 2001) . The levels of p53 acetylation are markedly induced upon various types of stresses, suggesting a major role of this kind of modification for mediating p53 transactivation under stress conditions. However, the precise mechanism by which p53 acetylation and deacetylation are regulated remains largely unknown because of the complex and dynamic changes of the various posttranslational modifications occurring on p53 (Levine et al., 2006; Brooks and Gu, 2008; Kruse and Gu, 2009 ). p300/CBP, p300/CBP-associated factor and Tip60 are well identified HATs responsible for p53 acetylation at the individual lysine residues, and therefore function as the cofactors for p53 transactivation (Avantaggiati et al., 1997; Lill et al., 1997; Liu et al., 1999; Sykes et al., 2006; Tang et al., 2006) . Conversely, the histone deacetylase complex containing histone deacetylase1 or human sirtuin 1 mediates p53 deacetylation and strongly represses p53 transactivation (Juan et al., 2000; Luo et al., 2000 Luo et al., , 2001 Vaziri et al., 2001) . The limited literature regarding the regulation of p53 acetylation or deacetylation only elucidates several protein factors and a small molecule that are involved in enhancing or suppressing p53 transactivity by targeting p300 (that is, Bat3, SOX4, ING2, Skp2) or sirtuin 1 (that is, AROS, DBS, tenovin-6; Pedeux et al., 2005; Kim et al., 2007; Sasaki et al., 2007; Lain et al., 2008; Zhao et al., 2008; Pan et al., 2009; Zhu et al., 2009) . Therefore, our results have added a novel member, p85a, to the list of the limited positive regulators of p53 acetylation that can cooperate with p300 to stimulate p53 acetylation under certain stress condition.
During the elucidation of the detailed mechanism by which p85a regulates p53 acetylation and transactivation in the cellular UVB response, we demonstrated that p85a binds to p300 (Figures 4a and b) , enhances the p53-p300 interaction (Figures 4c-e) , and subsequently promotes the recruitment of the p53-p300 complex to the p53-RE within the specific p53 target genes ( Figure 5 ) in response to UVB irradiation. In the absence of p85a, p53 is stabilized, phosphorylated, localizes into the nucleus (Figure 2 ), but fails to be acetylated (Figure 3) . Furthermore, the p53-p300 interaction (Figures 4c-e) and the promoter-specific binding ability of p53 ( Figure 5 ) are also impaired in p85a-null cells. These lines of evidence suggest that p85a has a critical role in promoter-specific p53 transactivation by facilitating p300-dependent p53 acetylation and enhancing the promoter-specific DNA binding ability of p53 in response to UVB exposure. Interestingly, p85a is also required for the autoacetylation of p53-associated p300 (Figures 4c-e) , which events may be helpful to upregulate HATs activity of p300 and then increase p53 transcriptional activity by promoting histone acetylation in the vicinity of p53-RE, and therefore altering the chromatin structure for the access of p53.
Although numerous reports have validated the critical role of lysine acetylation in p53 transactivation, a great debate still exists regarding if the occurrence of p53 acetylation regulates DNA-binding ability as well as the protein stability of p53 (Li et al., 2002; Feng et al., 2005; Sykes et al., 2006; Tang et al., 2008) . Data from Dr Okata and colleagues have shown that Bat3-dependent p53 acetylation at Lys373/382 is necessary for the sequence-specific DNA binding and the transactivation of p53; although it is not involved in regulating p85a-dependent p53 acetylation in UVB response L Song et al p53 accumulation in response to DNA damage (Sasaki et al., 2007) . Another group report that p53 acetylation mediated by SOX4, a recently identified regulator of the p53 pathway, affects both the protein stability and the cognate promoter-binding ability of p53 (Pan et al., 2009) . In our experimental system, p85a-dependent p53 acetylation at Lys370 does not affect p53 accumulation induced by UVB (Figures 3a and 6a, b) ; however, it has a critical role in regulating the promoter-specific DNAbinding ability of p53 ( Figure 5 ). Therefore, we propose that the different biological significance resulting from p53 acetylation under various stress conditions may be determined by the upstream regulator(s) involved.
In conclusion, our results have shown that p85a acts as the critical upstream mediator for p300-mediated p53 acetylation and promoter-specific transactivation in the cellular UVB response. As dysregulation of the p300-p53 pathway has been observed in many human cancers (Goodman and Smolik, 2000; Iyer et al., 2004) and the potential tumor suppressor role of p85a has been revealed (Yin et al., 1998; Miled et al., 2007) , it will be promising to evaluate the anticancer strategy by targeting p85a/p300/p53 pathway.
Materials and methods
Plasmids and antibodies
The p53-luciferase reporter plasmid, in which the transcription of the luciferase reporter gene is driven by the consensus p53-RE, has been described previously (Wang et al., 2005) . To construct the expression plasmid encoding wt mouse p53, p53 complementary DNA (cDNA) was amplified from p85a
MEFs using the primers 5 0 -ACAAGCTTATGACTGCCA TGGAGGAGTCA-3 0 and 5 0 -ATGGATCCTCAGTCTGAG TCAGGCCCCAC-3 0 and then inserted into the pCMVtag2B vector (Clontech, Mountain View, CA, USA). p53K370R mutant cDNA was amplified by regular overlapping PCR for gene mutagenesis and then inserted into the same vector to construct the expression plasmid encoding p53K370R. The antibodies against p53, p53-p-Ser18, p53-p-Ser389, p53-ACLys379, p300-AC-Lys1499, Bax, PUMA and GFP were purchased from Cell Signal Technology (Beverly, MA, USA). The antibodies against p85a, p300, HA, Egr-1, caspase-3, GADD45a, p21, GAPDH and p53 (for ChIP assay) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The antibodies against p53-AC-Lys370 and p53-AC-Lys317 were obtained from Upstate (Billerica, MA, USA). The anti-b-actin antibody was purchased from Sigma (St Louis, MO, USA).
(p85a) and p85a shRNA-stably transfected p85a þ / þ MEFs were described in the previous study (Song et al., 2007) . The p53 À/À MEFs were described in our previous study (Wang et al., 2005) . The MEFs were maintained in Dulbecco 0 s modied Eagle 0 s medium (Calbiochem, San Diego, CA, USA) supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin and 2 mM L-glutamine (Life Technologies, Inc., Rockville, MD, USA).
Cell transfection
All of the stable and transient transfections were performed with LipofacTAMINE reagents (Life Technologies, Inc.) according to the manufacturer's instructions. To establish p53 luciferase reporter stable transfectants in p85a þ / þ and p85a À/À MEFs, the p53 luciferase reporter construct was introduced into the cells together with lacZ-hygro þ , a vector conferring hygromycin-resistance. The according drug-resistant stable transfectants were established as a polyclonal mass under hygromycin B selection. To establish the p53 luciferase reporter stably transfected p85a À/À (p85a) MEFs, the p85a
MEFs were co-transfected with the expression plasmid encoding p85a, lacZ-hygro þ and the p53 luciferase reporter construct. The stable transfectant was also selected as described above under hygromycin B selection. To establish p53 luciferase reporter construct stably-transfected p85a þ / þ (p85a shRNA) MEFs, the p85a þ / þ MEFs were co-transfected with the p53 luciferase reporter construct and the expression plasmid encoding p85a shRNA or control shRNA. The stable transfectants were established under G418 selection. For transient transfection, the p53 À/À MEFs were transfected with wt p53 or p53K370R and then subjected to the next-step exposure 36 h after transfection. Western blot assay Cellular protein extracts were prepared with cell lysis buffer (10 mM Tris-HCl, pH 7.4, 1% SDS, 1 mM Na 3 VO 4 ) and resolved by SDS-polyacrylamide gel electrophoresis. The membranes were probed with the indicated primary antibodies and the AP-conjugated second antibody. Signals were detected by the ECF Western-blotting system as described in our previous reports (Song et al., 2006 (Song et al., , 2007 .
Luciferase reporter assay
MEFs with transient or stable transfection of the luciferase reporter constructs were seeded into 96-well plates (8 Â 10 3 per well) and subjected to the various treatments when cell density reached 80-90% confluence. Cellular lysates were prepared, and the luciferase activities were determined by a luminometer (Wallac 1420 Victor 2 multilabel counter system, Beckman, Fullerton, CA, USA) as described in our previous studies (Song et al., 2007 (Song et al., , 2008 . The results are expressed as relative activity that normalized to the control cells without treatment.
ChIP assay
The ChIP assay was performed with the EZ ChIPt Chromatin Immunoprecipitation Kit (Upstate) according to the manufacturer's protocol as described previously (Song et al., 2007) . To specifically amplify the region containing the putative p53-REs within the promoter region of mouse PERP and p21 genes, PCR was performed with the following pair of primers: PERP: 5 0 -TGAATGTTTGGCTTATATTTGTGGAG-3 0 (forward) and 5 0 -CCTTCTTTCAGTGCATACCTCATCCC-3 0 (reverse; Reczek et al., 2003) . p21: 5 0 -CCTTTCTATCAGCC p85a-dependent p53 acetylation in UVB response L Song et al CCAGAGGATACC-3 0 (forward) and 5 0 -GGGACATCCT TAATTATCTGGGGTC-3 0 (reverse).
Cell apoptosis assay
The percentage of apoptotic cells was determined by PIstaining of the nuclei followed by the flow cytometric assay as previously described (Song et al., 2007) .
